Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease

Sponsor
Oregon Health and Science University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05680597
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (NIH)
80
2
53

Study Details

Study Description

Brief Summary

This project will determine the feasibility and efficacy of remote assessment and treatment of balance disorders in people with Parkinson's disease.

Condition or Disease Intervention/Treatment Phase
  • Other: Balance Tele-Rehabilitation Agility Boot Camp (ABC)
N/A

Detailed Description

This project consists of a virtual balance assessment which will use objective measures of balance and gait obtained with wearable sensors (instrumented socks on the feet, Opal on the waist, sternum and wrists). During a virtual assessment, the Instrumented Stand and Walk Test (ISAW) will be conducted in 80 people with Parkinson's Disease (PD) to predict a gold-standard, clinical in-person assessment of balance, the Mini-Balance Evaluation System Test (mini-BESTest). For the balance tele-rehabilitation there will be 80 participants randomized into two groups: 1) unsupervised home Agility Boot Camp (ABC) exercises (standard of care), 2) balance (ABC) with therapist tele-rehabilitation, and mobility during daily-life to explore if improvements after tele-rehabilitation transfer to daily life mobility. The long-term goal of this project is to develop a more effective, home-based balance assessment and treatment that can be used in older adults with balance impairments to improve their safe independence during daily life.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
We will randomize the 80 participants into two groups: 1) unsupervised home Agility Boot Camp (ABC) exercises (standard of care), 2) supervised balance (ABC) with therapist tele-rehabilitation.We will randomize the 80 participants into two groups: 1) unsupervised home Agility Boot Camp (ABC) exercises (standard of care), 2) supervised balance (ABC) with therapist tele-rehabilitation.
Masking:
Single (Outcomes Assessor)
Masking Description:
Clinical pre- and post-testing will be carried out by a researcher who is blinded to group assignment. Scientists analyzing daily life monitoring data will also be blinded to pre-post status.
Primary Purpose:
Treatment
Official Title:
Balance Tele-rehabilitation With Wearable Technology for Older Adults With Parkinson's Disease
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Jun 1, 2027
Anticipated Study Completion Date :
Jun 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: Supervised Tele-Rehabilitation Home Exercise

40 subjects will have tele-rehabilitation virtually with a physical therapist for 60 minutes, three times per week for four weeks of intervention. Subjects will also be assessed for daily life mobility for seven days pre and post intervention with wearable sensors.

Other: Balance Tele-Rehabilitation Agility Boot Camp (ABC)
The intervention is tele-rehabilitation conducted by a physical therapist virtually for 60 minutes three times a week for four weeks. Subjects will be assessed for seven days pre and post intervention using the Opal sensors (APDM wearable technologies) to monitor daily mobility.
Other Names:
  • Opal sensors; APDM Wearable Technologies
  • Active Comparator: Unsupervised Rehabilitation Home Exercise

    40 subjects will complete their home exercise Agility Boot Camp (ABC) program for 60 minutes, three times per week for four weeks of intervention. Subjects will also be assessed for daily life mobility for seven days pre and post intervention with wearable sensors.

    Other: Balance Tele-Rehabilitation Agility Boot Camp (ABC)
    The intervention is tele-rehabilitation conducted by a physical therapist virtually for 60 minutes three times a week for four weeks. Subjects will be assessed for seven days pre and post intervention using the Opal sensors (APDM wearable technologies) to monitor daily mobility.
    Other Names:
  • Opal sensors; APDM Wearable Technologies
  • Outcome Measures

    Primary Outcome Measures

    1. Change from Baseline in the Mini-BESTest, a 14-item test of 4 domains of balance at week 4 [Baseline and 4 weeks]

      The Mini-BESTest, a 14-item test of 4 domains of balance, that has been well studied and is related to fall risk in people with Parkinson's disease.

    Secondary Outcome Measures

    1. Change from Baseline in the Modified Instrumented Stand and Walk Test (ISAW) at 4 weeks [Baseline and 4 weeks]

      In this test, the participant will don 3 sensors and will be instructed to stand for 30 seconds, walk 12 steps, turn around and walk back. The ISAW has the ability to characterize multiple domains of balance, similar to the Mini-BESTest, including postural sway in standing with feet together with eyes open for 30 seconds prior to step initiation and gait with a 180-degree turn.

    2. Change from Baseline in the Patient Global Impression of Change (PGIC), a seven point scale depicting the patient's impression of improvement, at 4 weeks [4 weeks of intervention]

      The PGIC is one question rated on a seven point Likert scale measuring impression of change after intervention.

    3. Montreal Cognitive Assessment (MoCA) [10 minutes]

      This test screens for thinking skills like memory and attention

    4. Parkinson's Disease Questionaire-39 (PDQ-39) [10 minutes]

      This is a questionnaire looking at how Parkinson's Disease affects your quality of life over the last month

    5. MDS-United Parkinson's Disease Rating Scale (UPDRS) [10 minutes]

      This is a clinical exam of Parkinson's Disease symptoms including stiffness, slowness and tremor

    6. Freezing of Gait Questionnaire (FoGQ) [5 minutes]

      This is a questionnaire asking about different situations that cause freezing of gait and how it may affect your balance (5 minutes). minutes to complete

    7. International Physical Activity Questionnaire- Short Form (IPAQ) [5 minutes]

      This questionnaire asks about intensity and type of physical activity performed in the last 7 days

    8. Wearable Sensors to Measure Daily Life Mobility (steps per day) [8-10 hours per day for 7 days]

      use instrumented socks and a sensor around the waist (APDM) to measure activity parameters such as steps per day

    9. Wearable Sensors to Measure Daily Life Mobility [8-10 hours per day for 7 days]

      use instrumented socks and a sensor around the waist (APDM) to measure quality measure such as turn angle

    10. Wearable Sensors to Measure Daily Life Mobility (turn speed) [8-10 hours per day for 7 days]

      use instrumented socks and a sensor around the waist (APDM) to measure quality measure such as turn speed over seven days of monitoring.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    55 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Diagnosis of idiopathic PD from movement disorders neurologist with the United Kingdom Brain Bank criteria of bradykinesia and one or more of the following - rest tremor, rigidity, and balance problems not from visual, vestibular, cerebellar or proprioceptive conditions

    2. responsive to levodopa (self-reported)

    3. Hoehn & Yahr 62 stages I-III;

    4. ages 55-85 years old

    5. ability to follow directions in order to participate in testing procedures and exercise classes

    6. free of any medical conditions or medication that contraindicates participation in an exercise program

    7. willing and able to participate in rehabilitation intervention 3x/week for 4 weeks while also refraining from other exercise programs or changes in medications during the study period.

    Exclusion Criteria:
    1. Major musculoskeletal or neurological disorders, structural brain disease, epilepsy, acute illness or health history, other than PD, significantly affecting gait and balance (i.e., musculoskeletal disorder, vestibular problem, head injury, stroke, cardiac disease, etc.)

    2. no medical condition that precludes exercise

    3. ≤ 21 Montreal Cognitive Assessment (MoCA), or prior diagnosis of dementia, or inability to follow directions

    4. recurrent fallers, defined as multiple falls each day (from patient and caregiver recollection)

    5. excessive use of alcohol or recreational drugs

    6. recent change in medication

    7. inability to stand and walk for ISAW without an assistive device.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Oregon Health and Science University
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    Investigators

    • Principal Investigator: Laurie A King, PhD, Oregon Health and Science University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Oregon Health and Science University
    ClinicalTrials.gov Identifier:
    NCT05680597
    Other Study ID Numbers:
    • 1R01HD107074-01
    • 1R01HD107074-01A1
    First Posted:
    Jan 11, 2023
    Last Update Posted:
    Jan 11, 2023
    Last Verified:
    Jan 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Oregon Health and Science University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 11, 2023